cGxP.wire https://validator.w3.org/feed/docs/rss2.html AcuraStem Secures $7.5M to Advance AS-241 for ALS and FTD BRC Therapeutics Secures FDA IND Clearance for BRC-002 Therapy BioLineRx & Hemispherian Dose First Patient in GLIX1 GBM Trial Latus Bio Advances Gene Therapy Programs for Rare CNS Diseases Affinia Therapeutics Advances AFTX-201 for BAG3 DCM Thermo Fisher Opens US Bioprocess Center to Boost Biologics Orca Bio Secures FDA RMAT Status for Orca-Q Therapy AstraZeneca Breztri Becomes First Triple Therapy Approved for Asthma in US GSK Bepirovirsen Wins FDA Priority Review Breakthrough Status Avenzo Therapeutics Advances Dual CDK Inhibitor Breast Cancer Study Abbott Ultreon 3.0 AI Imaging Gains FDA, CE Approval Quoin Pharmaceuticals Expands QRX009 Topical Rapamycin Pipeline PharmaLogic Opens PET Radiopharma Facility in Atlanta Pixee Medical Knee+ NexSight Wins FDA 510(k) Clearance IGC Pharma Strengthens CALMA Trial Through Caregiver Outreach MediciNova Advances Brain Metastasis Therapy With MN-166 Taiho Zipalertinib NDA Accepted by FDA for NSCLC Sapient Launches Tumor Protein Mapping Platform for Oncology VectorY Therapeutics Secures EMA and MHRA Approval for VTx-002 Trial SQ Innovation Lasix ONYU Gains CE Mark EMA Review Scancell Advances Cancer Immunotherapy Pipeline Momentum Mirai Bio Advances Targeted LNP Delivery at ASGCT Sail Biomedicines Advances In Vivo eRNA CAR-T Data Encoded Therapeutics Showcases ETX101 Data at ASGCT Boehringer Survodutide Shows 16.6% Weight Loss in Phase III Elanco Secures EUA for Screwworm Treatment in Livestock Fathom Therapeutics Raises $47M to Advance AI Drug Design Ferrotec Introduces Ferrobeads for High-Efficiency DNA RNA Isolation Zentiva Appeals EU Wastewater Directive Impact on Pharma Cellenkos Wins FDA Clearance for CK0801 Phase 2 Trial Galaxy Therapeutics Submits PMA for SEAL Device FDA Johnson & Johnson Strengthens CNS Portfolio with CAPLYTA FDA Nod Apotex Secures FDA Approval for Infuvite Pediatric Injection TytoCare Wins FDA De Novo for AI ENT Diagnostics Dark Horse Consulting Group Partners with Porton Advanced for IITs AstraZeneca Saphnelo Pen Gains FDA Approval in US Eli Lilly to Acquire Ajax Therapeutics in $2.3B Oncology Deal Santhera Pharmaceuticals Gains EU Boost for AGAMREE Expansion Clinuvel Advances Vitiligo Phase 3 with EMA Support Adagio Medical Reports Positive vCLAS Results for VT Novartis Itvisma Gains CHMP Boost for SMA Therapy Johnson & Johnson PERSIGMA Trial Advances AFib Care BrioHealth Strengthens MedTech Pipeline with FDA Approval CGBIO Wins FDA IDE for NOVOSIS PUTTY Spine Trial OrthoTrophix TPX-100 Shows Breakthrough in Knee OA Study Arrowhead Gains CHMP Nod for REDEMPLO in Rare Disease Abbott Showcases AFib Tech Breakthrough at HRS 2026 Medtronic Affera Catheters Show Strong HRS 2026 Data Cerapedics Expands PearlMatrix Access via Vizient Deal Ascletis Advances ASC30 Phase II Trial in Diabetes